CCR2 expression on monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT

Verweij, Simone L.; Moens, Sophie Bernelot; Duivenvoorden, Raphaël; Nurmohammed, Nick; Verberne, Hein J.; Stroes, Erik S.G.; Bekkering, Siroon

doi:10.1016/j.atherosclerosis.2017.06.286

Atherosclerosis

2017

DOI: 10.1016/j.atherosclerosis.2017.06.286

|View full text |Cite

CCR2 expression on monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT

Simone L. Verweij¹,

Sophie Bernelot Moens²,

Raphaël Duivenvoorden³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, CCR2 1 monocytederived cardiac macrophages are required for adverse left ventricle remodeling (7). CCR2 is involved in the onset of a variety of diseases associated with diabetes, cardiovascular disease, hypertension, renal disease, and neurodegenerative disorders (5,(8)(9)(10)(11). These observations lead us to hypothesize that CCR2 induces recruitment of monocytes/macrophages that regulate diabetic cardiomyopathy.…”

mentioning

confidence: 99%

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Tan

Shu

et al. 2019

Diabetes

View full text Add to dashboard Cite

CCR2 has been proven to play an important role in diabetes. However, the role of CCR2 in diabetic cardiomyopathy has not been examined. In this study, we investigated the effects of cardiac CCR2 on diabetic cardiomyopathy. We created a model of streptozotocin (STZ)-induced diabetic cardiomyopathy. Expression of CCR2 was upregulated in the hearts of STZ-induced diabetic mice. CCR2 knockout significantly improved STZ-induced cardiac dysfunction and fibrosis. Moreover, deletion of CCR2 inhibited STZ-induced apoptosis and the production of STZ-induced reactive oxygen species in the heart. CCR2 knockout resulted in M2 polarization in hearts of STZ-treated mice. Treatment with a CCR2 inhibitor reversed hyperglycemia-induced cardiac dysfunction in db/db mice. These results suggest that CCR2-induced inflammation and oxidative stress in the heart are involved in the development of diabetic cardiomyopathy and that CCR2 could be a novel target for therapy.

show abstract

mentioning

confidence: 99%

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Tan

Shu

et al. 2019

Diabetes

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

CCR2 expression on monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT

Cited by 1 publication

References 0 publications

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Contact Info

Product

Resources

About